Tenoxicam

Jump to: navigation, search
Tenoxicam
Tenoxicam Wiki Str.png
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
Pharmacokinetic data
Protein bindingHigh
Elimination half-life30–140 hours
Identifiers
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H11N3O4S2
Molar mass337.376 g/mol
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Tenoxicam

Articles

Most recent articles on Tenoxicam

Most cited articles on Tenoxicam

Review articles on Tenoxicam

Articles on Tenoxicam in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tenoxicam

Images of Tenoxicam

Photos of Tenoxicam

Podcasts & MP3s on Tenoxicam

Videos on Tenoxicam

Evidence Based Medicine

Cochrane Collaboration on Tenoxicam

Bandolier on Tenoxicam

TRIP on Tenoxicam

Clinical Trials

Ongoing Trials on Tenoxicam at Clinical Trials.gov

Trial results on Tenoxicam

Clinical Trials on Tenoxicam at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tenoxicam

NICE Guidance on Tenoxicam

NHS PRODIGY Guidance

FDA on Tenoxicam

CDC on Tenoxicam

Books

Books on Tenoxicam

News

Tenoxicam in the news

Be alerted to news on Tenoxicam

News trends on Tenoxicam

Commentary

Blogs on Tenoxicam

Definitions

Definitions of Tenoxicam

Patient Resources / Community

Patient resources on Tenoxicam

Discussion groups on Tenoxicam

Patient Handouts on Tenoxicam

Directions to Hospitals Treating Tenoxicam

Risk calculators and risk factors for Tenoxicam

Healthcare Provider Resources

Symptoms of Tenoxicam

Causes & Risk Factors for Tenoxicam

Diagnostic studies for Tenoxicam

Treatment of Tenoxicam

Continuing Medical Education (CME)

CME Programs on Tenoxicam

International

Tenoxicam en Espanol

Tenoxicam en Francais

Business

Tenoxicam in the Marketplace

Patents on Tenoxicam

Experimental / Informatics

List of terms related to Tenoxicam

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID). It is manufactured by Roche under the trade name Mobiflex. It is available in the United Kingdom as a prescription-only drug. Tenoxicam belongs to the class of NSAIDs known as oxicams. It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints).

Contraindications

The drug is contraindicated for patients who are seniors who have been given anesthesia or surgery; are at risk of increased bleeding or kidney failure; have an active inflammatory disease involving the stomach or intestine (like ulcerative colitis); have an active stomach or intestinal ulcer; have had an acute asthmatic attack, hives, rhinitis (inflammation of the inner lining of the nasal passage), or other allergic reactions caused by Aspirin or other nonsteroidal anti-inflammatory drugs (for example diclofenac, ibuprofen, indomethacin, naproxen).

See also

References

Template:Musculoskeletal-drug-stub


Linked-in.jpg